EcoR1 Targets Biotech Company

The hedge fund founded by 2015 Hedge Fund Rising Star Oleg Nodelman bought nearly 9 million shares in a developmental company in one day.

Oleg Nodelman (Amanda Gordon/Bloomberg)

Oleg Nodelman

(Amanda Gordon/Bloomberg)

A little known but successful hedge fund that specializes in biotech companies has taken a huge and possibly activist stake in a clinical-stage biotechnology company whose stock is badly beaten down.

On August 23, Oleg Nodelman’s EcoR1 Capital bought a little more than 8.7

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.